Since 2007 PCFA has administered one of the largest prostate cancer research funding programs in Australia. Our decade-long partnership with The Movember Foundation has led to the establishment of numerous prostate cancer research centres nationally.
We currently fund projects that translate basic research outcomes into new initiatives and therapies, with the goal of reducing the impact of prostate cancer on our community.
PCFA is considering changing its research strategy to one that is more proactive in identifying issues that need research. Development of a new Funding Strategy 2018-2022 is underway.
During this process, PCFA will be consulting with its stakeholders - the community, supporters, researchers and health professionals.
Our Research Mission
To enable acquisition of knowledge that will reduce the impact of prostate cancer on Australian men, their partners and families, recognising the diversity of the Australian community.
Our Research Strategy
Research is a long and expensive process. Funding for medical science can be difficult to obtain in Australia, with many excellent researchers competing for government grants. Unfortunately this means that good projects often go un-funded and important discoveries are not translated into positive outcomes for patients and the community. PCFA's research program aims to secure funding for vital prostate cancer research, focusing on priority areas that are strongly related to our mission.
Our research strategy supports research that benefits patients, such as clinical trials and research into the lived experience of men with prostate cancer, whilst continuing to support basic research. We fund three pillars of research:
- Basic science: new discoveries are made using test tubes and cells in the laboratory
- Clinical science: the safety and effectiveness of new drugs, products, diagnostic tools and devices are tested for use in humans
- Survivorship research: research into the lived experience for men with prostate cancer and their families, including interventions to improve their lives, during and after prostate cancer treatment